Formulation, Optimization, and Characterization of Repaglinide Loaded Nanocrystal for Diabetes Therapy

Table 3

Taguchi orthogonal experimental design.

Batch
NC 1	PEG-4000	0.75%	5	500
NC 2	PEG-4000	1.5%	8	1000
NC 3	PEG-4000	2.25%	10	1500
NC 4	PLURONIC-F68	0.75%	8	1500
NC 5	PLURONIC-F68	1.5%	10	500
NC 6	PLURONIC-F68	2.25%	5	1000
NC 7	PVA	0.75%	10	1000
NC 8	PVA	1.5%	5	1500
NC 9	PVA	2.25%	8	500